VALENTI, LUCA VITTORIO CARLO
VALENTI, LUCA VITTORIO CARLO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation
2026 F. Malvestiti, A. Lombardi, F. Gentile, V. Torcianti, E. Trombetta, A. Cherubini, G. Lamorte, S.C.U. Renteria, D. Marchelli, L. Rosso, A. Bandera, F. Peyvandi, F. Blasi, G. Grasselli, L. Porretti, S. Alqahtani, D. Prati, R. Gualtierotti, B. Soskic, V. Vaira, L. Ronzoni, L. Valenti
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis-Related Fibrosis: Therapeutic Options and Approaches to Treatment
2026 M. Tincopa, E. Speliotes, L. Valenti, R. Loomba
Sex Differences in Cancer-Associated Thrombosis
2026 A. Giachi, D. Santagata, A. Truma, A. Artoni, P. Bucciarelli, L. Valenti, C. Ay, R. Gualtierotti
Early BAL microRNA Signatures Delineate Biological Trajectories Towards CLAD After Lung Transplantation
2026 G. Gaudioso, S. Franzi, R. Orlandi, M.R.D. Filippo, A. Terrasi, A.M. Storaci, N. Mansour, B. Digiuni, D. Marchelli, L.V.C. Valenti, G.D. Turris, F. Von Herz, G. Garulli, M. Nosotti, L.C. Morlacchi, F. Blasi, A. Palleschi, V. Vaira
Once-monthly efimosfermin for non-cirrhotic MASH
2026 L. Valenti, G. Periti
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
2026 H. Zhang, Q. Chen, G. Lip, H. Tilg, L. Valenti, V. Somers, C. Byrne, G. Targher, W. Yang, C. Mantzoros, A. Misra, A. Lonardo, K. Alswat, K. Sung, M. Muthiah, X. Zhou, M. Zheng
Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling
2026 F. Yang, W. Wang, F. Qiu, R. Qing, Q. Gao, X. Yan, D. Wu, H. Hui, R. Dang, G. Jiang, L. Han, C. Long, S. Hua, Y. Zhang, S. Ji, L. Xu, C. Zhou, D. Xu, A. Cherubini, L. Valenti, P. Gu, S. Zang, W. Jiang, Z. Huang
MASLD in Adults With Type 1 Diabetes and Type 2 Diabetes Undergoing Vibration-Controlled Transient Elastography
2026 A. Mantovani, E. Scoccia, R. Morandin, M. Lando, V. Fiorio, A. Taverna, I. Milani, M. Chinucci, M. Parrotta, L. Colangeli, S. Palleschi, P. Sbraccia, F. Leonetti, L. Valenti, D. Capoccia, G. Targher, V. Guglielmi
Prevalence, type, and clinical implications of CFTR variants in bronchiectasis
2026 A. Gramegna, L. Allavena, G. Alicandro, E. Canella, M. Nigro, C. Premuda, M. Ori, M. Santambrogio, L. Porcaro, D. Prati, L. Valenti, S. Aliberti, F. Blasi
Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
2026 L. Miano, E. Sinopoli, A. Cherubini, C. Suffritti, S. Pelusi, F. Rahmeh, G.E. Lamorte, F. Peyvandi, F. Blasi, G. Grasselli, A. Bandera, R. Gualtierotti, D. Prati, L.V.C. Valenti
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma
2026 M. Mureddu, S. Pelusi, O. Jamialahmadi, M. Vujkovic, L. Miano, H. Eidgah Torghabehei, L. Ronzoni, F. Malvestiti, M. Saracino, G. Periti, V. Moretti, C. Teerlink, J. Lynch, P. Tsao, J. Johnson, V. La Mura, R. Dilena, S. Alqahtani, A. Cherubini, F. Russo, R. D'Ambrosio, M. Fraquelli, S. Petta, L. Miele, U. Vespasiani-Gentilucci, E. Bugianesi, R. Mancina, P. Parini, D. Prati, K. Chang, C. Schneider, S. Romeo, L. Valenti
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study
2026 G. Caviglia, A. Ferro, R. D'Ambrosio, R. Perbellini, P. Lampertico, G. Periti, L. Valenti, C. Ciccioli, G. Pennisi, S. Petta, L. Brodosi, M. Petroni, F. Marchignoli, L. Pironi, A. Sagripanti, M. Argenziano, G. Svegliati-Baroni, C. Rosso, F. Barutta, A. Armandi, G. Gruden, E. Bugianesi
Safety Choice Drivers of the Coming Treatment Options for Non-Cirrhotic Metabolic Steatohepatitis
2025 A. Mangia, L. Valenti
Metabolic dysfunction-associated steatotic liver disease
2025 G. Targher, L. Valenti, C. Byrne
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021
2025 C. Wu, G. Targher, C. Byrne, Y. Mao, T. Cheung, Y. Yilmaz, L. Valenti, N. Méndez-Sánchez, S. Sookoian, W. Chan, S. Treeprasertsuk, H. Yu, S. Kim, J. George, D. Hu, G. Sebastiani, J. Ryan, R. Oviedo, J. Zhong, J. Schattenberg, A. Lonardo, E. Ruiz-Úcar, W. Seto, M. Sotoudeheian, P. Ocama, M. Lupşor-Platon, T. Yang, H. Ghazinyan, Q. Pan, S. Hamid, L. Adams, J. Chai, A. Prasad, N. Perera, K. Alswat, V. Isakov, S. Sarin, A. Sharara, F. Sanai, S. Al-Busafi, C. Opio, C. Toro-Huamanchumo, W. Yang, Y. Wong, G. Torzilli, Y. Fouad, M. Zheng
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease
2025 M. Scaravaglio, L. Ronzoni, L. Cristoferi, L. Miano, E. Nofit, A. Gerussi, F. Malinverno, V. Moretti, V. Torcianti, C. Caime, M. Cadamuro, L. D'Antiga, P. Invernizzi, M. Carbone, L. Valenti
Age- and sex-specific lipoprotein profiles in general and cardiometabolic population cohorts
2025 R. Conde, R. Gil-Redondo, M. Bizkarguenaga, S. Lodge, P. Nitschke, Á. De Diego, B. González-Valle, J. Hui, M. Hunter, B. Yeap, A. Cenarro, V. Lope, H. Habisch, C. Haudum, N. Verheyen, B. Obermayer-Pietsch, M. Zaro Bastanzuri, M. González Fernández, D. Fernández-Bergés, A. Salazar, M. Sorando-Fernandez, S. Meijide, G. Hernandez, E. Arana, M. Seco, A. Sousa, N. Oliveira, I. Verde, T. Madl, M. Unda-Urzaiz, A. Carracedo, T. Diercks, A. Castelló, H. Schäfer, M. Spraul, C. Cannet, N. Embade, L. Valenti, F. Civeira, S. Lu, E. Holmes, J. Wist, J. Nicholson, J. Mato, O. Millet
SLC7A11 transporter maintains critical nonessential amino acids levels to hamper ferroptosis during MASLD progression
2025 E. Casirati, L. Valenti
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
2025 Y. Vali, A. Van Dijk, J. Lee, J. Boursier, V. Ratziu, C. Yunis, J. Schattenberg, L. Valenti, M. Gomez, D. Schuppan, S. Petta, M. Allison, M. Hartman, K. Porthan, J. Dufour, E. Bugianesi, A. Gastadelli, Z. Derdak, C. Fournier-Poizat, E. Shumbayawonda, M. Kalutkiewicz, H. Yki-Jarvinen, M. Ekstedt, A. Geier, A. Trylesinski, S. Francque, C. Brass, M. Pavlides, A. Holleboom, M. Nieuwdorp, Q. Anstee, P. Bossuyt
Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease
2025 O. Jamialahmadi, E. Mujica, L. Morris, R. Mancina, E. Ciociola, S. Qadri, S. Maurotti, F. Malvestiti, R. Li-Gao, L. Ronzoni, F. Tavaglione, H. Maude, A. Allalou, A. Emmanouilidou, U. Vespasiani-Gentilucci, F. Rosendaal, H. Yki-Järvinen, I. Cebola, L. Valenti, M. Hoed, S. Romeo